GS-441524 powder is the pure, powdered form of the antiviral compound GS-441524, which has shown significant effectiveness in treating feline infectious peritonitis (FIP), a deadly disease caused by a mutated form of the feline coronavirus. This powdered form is typically used as a base ingredient in the preparation of other GS-441524 formulations, such as injectable solutions or tablets, to customize dosing for individual treatment plans. The powder allows for precise control over dosage, which is essential for treating different stages and forms of FIP (effusive or non-effusive) in cats of various weights and health conditions.
By mixing GS-441524 powder with a suitable solvent, veterinarians can create injectable solutions with exact concentrations, tailored to the specific needs of each cat. Alternatively, it can be formulated into capsules or tablets for oral administration, though absorption and bioavailability can vary compared to injections. The flexibility of the powder form is advantageous for suppliers and veterinarians who need to adjust the concentration based on clinical requirements, severity of infection, and the cat’s tolerance.
| Property | Details |
|---|---|
| CAS Number | 1191237-69-0 |
| Grade | Pharmaceutcial Grade |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
| Density | 1.84±0.1 G |
| Appearance | White Powder |
| Storage | Store At Cool Dry Place |
| Molecular Weight | 291.26 |
| Purity |
99.0% |
GS441524 is a medication used to treat feline infectious peritonitis (FIP). Below are the general guidelines for using GS441524 powder, but specific usage should be adjusted according to a veterinarian's instructions:
1. Dosage:
The typical dosage depends on the cat's weight and the severity of the condition. The recommended dosage is usually 4-6 mg/kg of body weight, but higher doses may be required for severe cases.
2. Preparation:
GS441524 powder needs to be dissolved in sterile water or another appropriate solvent. Preparation should be done in a clean, sterile environment to ensure the stability and effectiveness of the medication.
3. Injection:
The dissolved solution is usually administered via subcutaneous or intravenous injection. For subcutaneous injection, choose a soft skin area (such as the back or shoulder) and use a sterile syringe. Intravenous injection should be performed by a professional veterinarian.
4. Frequency and Duration:
Generally, the injection is given once daily for at least 12 weeks. During the treatment, regular blood tests and other diagnostic evaluations are necessary to monitor the treatment's effectiveness and adjust the dosage as needed.
5. Precautions:
Ensure all equipment (syringes, solvents, etc.) is sterile.
Avoid overdosing to prevent potential toxicity and side effects.
If any adverse reactions occur during treatment, contact a veterinarian immediately.
The specific method and dosage should be determined and adjusted by a veterinarian based on the cat's condition. Always consult a professional veterinarian and follow their instructions precisely when using GS441524 powder.
